OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Release Date
2024
(4)
2022
(3)
2021
(2)
2026
(1)
2025
(1)
2020
(1)
2018
(1)
2016
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
Not available
S-EPMC9894241
|
biostudies-literature
Cite
Aging and comprehensive molecular profiling in acute myeloid leukemia.
Not available
S-EPMC10927507
|
biostudies-literature
Cite
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
Not available
S-EPMC9169777
|
biostudies-literature
Cite
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.
Not available
S-EPMC11560503
|
biostudies-literature
Cite
Ultrahigh-energy gamma-ray emission associated with black hole-jet systems.
Not available
S-EPMC12746838
|
biostudies-literature
Cite
Probing CP symmetry and weak phases with entangled double-strange baryons.
Not available
S-EPMC9159954
|
biostudies-literature
Cite
Extracting the femtometer structure of strange baryons using the vacuum polarization effect.
Not available
S-EPMC11470094
|
biostudies-literature
Cite
The Genetic Architecture of Depression in Individuals of East Asian Ancestry: A Genome-Wide Association Study.
Not available
S-EPMC8482304
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Using CSF biomarkers to replicate genetic associations in Alzheimer's disease.
Not available
S-EPMC3150628
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets